New research reveals the shingles vaccine may cut vascular dementia risk by half, offering unexpected brain protection beyond ...
Globally, synovial sarcoma remains a rare but aggressive malignancy with a 5-year survival rate of 70% to 80% and a 10-year ...
Adults older than 50 who received the shingles vaccination experienced a decreased risk in heart disease, dementia and death, according to Ali Dehghani, DO, of Case Western Reserve University during a ...
Infectious disease researchers found the vaccine, used to prevent herpes zoster, or shingles, is also linked to lower risks ...
The Canadian case study posters featured four unique clinical cases, part of a larger series, observing changes in wound size, pain, exudate, and tissue regranulation over time in patients with ...
Familial clustering was identified in primary hyperparathyroidism, as first-degree relatives were at higher risk than control patients.
News-Medical.Net on MSN
Study suggests earlier start of hormone therapy optimizes long-term health outcomes
Menopause may take a toll on women physically and emotionally due to declining estrogen levels. For some, the use of hormone ...
Individuals diagnosed with chronic spontaneous urticaria (CSU) are at a moderately increased risk of multiple cardiovascular ...
The shingles vaccine does more than just protect middle-aged folks and seniors against maddening rashes, a new study says.
Some U.S. hospitals that operate in-house dialysis services might benefit from outsourcing them, as inpatient discharge and length of stay rates increase, according to an analysis from Sg2, a Vizient ...
Stocktwits on MSN
MediciNova Stock Rockets 85% After-Hours On Promising Heart Study — Traders Hope For ‘Big Green Candle’
The newly published study showed that MediciNova’s compound tipelukast (MN-001) and its metabolite MN-002 helped the body ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results